Medical marijuana is used to treat a wide range of conditions such as chronic pain, and neurological disorders. The rising product launches are driving the growth of the market. For instance, in July 2020, the FDA has approved THC-based medications, dronabinol (Marinol) and nabilone (Cesamet), for the treatment of nausea in patients undergoing cancer chemotherapy and to stimulate appetite in patients with wasting syndrome due to AIDS. In addition, several marijuana-based medications have been approved or are undergoing clinical trials. For instance, Nabiximols (Sativex), a mouth spray is used in the treatment of spasticity and neuropathic pain.
MARKET DYNAMICS
The marijuana medicine market is driving due to rising awareness regarding various medical applications such as pain management, and growing number of countries legalizing the use of medical marijuana. However, lower market access due to absence of legalization programs in several Asian and African countries is expected to hamper the growth of the global marijuana medicine market. Moreover, growing research and development activities is anticipated to drive demand the growth of the market.
MARKET SCOPE
The "Marijuana Medicine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of marijuana medicine market with detailed market segmentation by application, and route of administration. The marijuana medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Marijuana Medicine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The marijuana medicine market is segmented based on application, and route of administration. Based on application, the market is segmented into chronic pain, arthritis, migraine, cancer, epilepsy, and others. Based on route of administration, the market is segmented into inhalation, oral, and topical.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Marijuana Medicine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Marijuana Medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting marijuana medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Marijuana Medicine market in these regions.
MARKET PLAYERS
The report covers key developments in the marijuana medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Marijuana Medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Marijuana Medicine market in the global market. Below mentioned is the list of few companies engaged in the Marijuana Medicine market.
The report also includes the profiles of key players in marijuana medicine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Greenwich Biosciences, Inc.
- Insys Therapeutics, Inc.
- Lexaria Bioscience Corp
- GW Pharmaceuticals plc
- GBSciences, Inc.
- Cara Therapeutics
- Avecho Biotechnology Ltd
- Solvay
- Intec Pharma Ltd
- Zelira Therapeutics
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.